CELESTE, Maria Grazia; DE MARCO, Francesca; FRESCO, Claudio; MUSUMECI, Giuseppe; RAVASIO, Roberto. Budget impact analysis of dabigatran compared with rivaroxaban in the prevention of the thromboembolic risk in patients with non-valvular atrial fibrillation. Farmeconomia. Health economics and therapeutic pathways, [S. l.], v. 18, n. 1, 2017. DOI: 10.7175/fe.v18i1.1327. Disponível em: https://provafe.seedstm.com/index.php/FE/article/view/1327. Acesso em: 23 jul. 2025.